Fermer le menu


Dendritics develops and markets mouse and rat monoclonal antibodies targeting the dendritic cells and their micro-environment, as tools for research and diagnostic. Dendritics also proposes on-demand:

Generation of monoclonal  antibodies, production (in vitro system, no use of ascites), purification and conjugation of monoclonal antibodies.

Dendritics markets an innovative process packaged as a transferable kit intended for multi species B cell activation and immortalization: the Blood B Booster(towards genuine monoclonal antibodies)

B cell immortalization is also offered as services on-demand.

Dendritics offers multi species monoclonal antibodies isolation from such immortalized B cells.


Strategic application domain: In Vitro diagnostic

Application market: Infectious Diseases, Oncology

Type of activity: Technology provider, Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide, Screening methods or services

Created on nov. 3rd, 2005 - 7 employees



60, avenue Rockefeller 69008 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.